Torrey Loper
Patients with structural heart disease can take very different routes before reaching the heart team. It can be difficult to reduce variability in care across the hospital system for this large patient population.
New appointments add structural heart, cardiothoracic surgery, and real-world outcomes expertise to advance egnite’s cardiovascular intelligence platform ALISO VIEJO, Calif. — June 18, 2026 — egnite, Inc., a healthcare AI company focused on helping clinicians identify and manage patients with untreated heart disease, today announced the expansion of its Medical Advisory Board (MAB). Joining the MAB are three distinguished cardiovascular specialists: Vijay Iyer, MD, PhD, FACC, Chief
egnite’s CardioCare Research Suite now identifies Lp(a) patients at health system scale, helping clinical trial teams to successfully find patients with elevated Lp(a) who were previously undetected due to current limitations in technology and workflow.
egnite, Inc., a leading digital health company specializing in cardiovascular care, today announced the addition of two distinguished physicians, Vinod H. Thourani, MD and Nicholas Amoroso, MD to its Medical Advisory Board. Their wealth of expertise in cardiovascular care and dedication to innovation will significantly contribute to egnite’s mission to improve cardiovascular patient care nationwide.